Open AccessA Prospective Phase II Clinical Trial of CD26/Dipeptidyl Peptidase (DPP)-IV Inhibition for Prevention of Acute Graft Versus Host Disease (aGVHD) Following Myeloablative Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation.
Author(s) -
Sherif Farag,
Mohammad Abu Zaid,
Robert P. Nelson,
Jennifer E. Schwartz,
Teresa C. Thakrar,
Carol Huntley,
Anne J Blakley,
Rafat Abonour,
Michael J. Robertson,
Shuhong Zhang
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.096
Subject(s) - medicine , sitagliptin , graft versus host disease , transplantation , immunology , gastroenterology , insulin , metformin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom